Seagen Inc. Insider Trading for November 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Seagen Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Seagen Inc. for November 2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 17 2017 | SGEN | SEATTLE GENETICS I ... | LIPPMAN MARC E | Director | Sell | S | 58.07 | 3,000 | 174,224 | 132,050 | 135.1 K to 132.1 K (-2.22 %) |
| Nov 17 2017 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Option Exercise | M | 26.10 | 10,000 | 261,000 | 28,429 | |
| Nov 17 2017 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Option Exercise | M | 26.10 | 6,911 | 180,377 | 38,429 | |
| Nov 17 2017 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Option Exercise | M | 15.46 | 8,489 | 131,240 | 0 | |
| Nov 17 2017 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Option Exercise | M | 15.46 | 9,600 | 148,416 | 8,489 | |
| Nov 17 2017 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Sell | S | 59.13 | 10,000 | 591,250 | 117,424 | 127.4 K to 117.4 K (-7.85 %) |
| Nov 17 2017 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Buy | M | 26.10 | 10,000 | 261,000 | 127,424 | 117.4 K to 127.4 K (+8.52 %) |
| Nov 17 2017 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Sell | S | 57.95 | 8,489 | 491,938 | 117,424 | 125.9 K to 117.4 K (-6.74 %) |
| Nov 17 2017 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Buy | M | 15.46 | 8,489 | 131,240 | 125,913 | 117.4 K to 125.9 K (+7.23 %) |
| Nov 17 2017 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Sell | S | 57.98 | 6,911 | 400,700 | 117,424 | 124.3 K to 117.4 K (-5.56 %) |
| Nov 17 2017 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Buy | M | 26.10 | 6,911 | 180,377 | 124,335 | 117.4 K to 124.3 K (+5.89 %) |
| Nov 17 2017 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Sell | S | 57.80 | 9,600 | 554,837 | 117,424 | 127 K to 117.4 K (-7.56 %) |
| Nov 17 2017 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Buy | M | 15.46 | 9,600 | 148,416 | 127,024 | 117.4 K to 127 K (+8.18 %) |
| Nov 14 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 11.09 | 17,109 | 189,739 | 169,487 | |
| Nov 14 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 11.09 | 1,723 | 19,108 | 186,596 | |
| Nov 14 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 57.95 | 17,109 | 991,467 | 687,146 | 704.3 K to 687.1 K (-2.43 %) |
| Nov 14 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 11.09 | 17,109 | 189,739 | 704,255 | 687.1 K to 704.3 K (+2.49 %) |
| Nov 14 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 58.46 | 1,723 | 100,727 | 687,146 | 688.9 K to 687.1 K (-0.25 %) |
| Nov 14 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 11.09 | 1,723 | 19,108 | 688,869 | 687.1 K to 688.9 K (+0.25 %) |
| Nov 03 2017 | SGEN | SEATTLE GENETICS I ... | SIMPSON TODD E | Chief Financial Off ... | Sell | S | 61.59 | 534 | 32,889 | 178,992 | 179.5 K to 179 K (-0.30 %) |
| Nov 03 2017 | SGEN | SEATTLE GENETICS I ... | SIMPSON TODD E | Chief Financial Off ... | Sell | S | 60.90 | 38,851 | 2,366,026 | 179,526 | 218.4 K to 179.5 K (-17.79 %) |